34718394|PMC8574487
{'Disease', 'Species', 'Gene'}
As Louisiana confronted its latest COVID-19 surge, clinicians at Ochsner Health realized they needed to vastly scale up outpatient monoclonal antibody therapy to keep patients from getting critically ill and occupying scarce hospital beds. Bochenek said UK HealthCare had administered COVID-19 monoclonal antibody therapy to 88 patients at an infusion clinic that operated from December 1, 2020, to March 14, 2021. She said the graduates are undergoing board certification but haven't yet entered the workforce.